Empagliflozin benefits in patients with heart failure and preserved ejection fraction
Crossref DOI link: https://doi.org/10.1038/s41591-022-02050-4
Published Online: 2022-12-09
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Text and Data Mining valid from 2022-12-01
Version of Record valid from 2022-12-01
Article History
First Online: 9 December 2022